Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 701,648 | 729,142 | 816,007 | 559,580 | 884,449 |
| Marketable Securities | 174,776 | 196,594 | 120,844 | 2,294,368 | 603,134 |
| Receivables | 734,512 | 692,066 | 609,320 | 585,050 | 489,319 |
| Inventories | 573,340 | 522,410 | 564,145 | 373,266 | 318,713 |
| Income taxes - deferred | 172,691 | 219,700 | 245,916 | 113,602 | 101,948 |
| Other current assets | 40,118 | 32,121 | 22,863 | 62,138 | 56,771 |
| TOTAL | $2,447,174 | $2,440,559 | $2,429,206 | $4,032,400 | $2,491,869 |
| Non-Current Assets | |||||
| PPE Net | 391,016 | 377,067 | 361,299 | 288,105 | 253,760 |
| Investments And Advances | 1,110,659 | 934,722 | 452,715 | 350,495 | 1,812,083 |
| Intangibles | 130,188 | 131,409 | 0 | 0 | 0 |
| Other Non-Current Assets | 746,743 | 731,622 | 842,761 | 628,132 | 621,936 |
| TOTAL | $2,378,606 | $2,174,820 | $1,656,775 | $1,266,732 | $2,687,779 |
| Total Assets | $4,825,780 | $4,615,379 | $4,085,981 | $5,299,132 | $5,179,648 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 305 | 307 | 18,747 | 60,115 | 60,249 |
| Accounts payable and accrued liabilities | 265,264 | 297,267 | 367,029 | 207,806 | 153,817 |
| Accrued Expenses | 86,647 | 86,978 | 75,659 | 76,156 | 64,392 |
| TOTAL | $751,725 | $710,486 | $764,276 | $581,829 | $507,968 |
| Non-Current Liabilities | |||||
| Long Term Debt | 107,335 | 95,966 | 91,847 | 80,421 | 139,417 |
| Deferred Revenues | 18,906 | 27,628 | 17,777 | 16,757 | 13,568 |
| Other Non-Current Liabilities | 1,411,680 | 1,357,889 | 1,353,091 | 1,300,000 | 1,300,000 |
| TOTAL | $1,584,992 | $1,522,214 | $1,505,987 | $1,418,473 | $1,473,766 |
| Total Liabilities | $2,336,717 | $2,232,700 | $2,270,263 | $2,000,302 | $1,981,734 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,852,717 | 1,667,667 | 1,858,656 | 1,839,308 | 1,827,365 |
| Common Shares | 926 | 466 | 922 | 459 | 456 |
| Retained earnings | -519,875 | -498,031 | -891,363 | 774,284 | 826,448 |
| Other shareholders' equity | -6,050 | -5,051 | 2,221 | 6,062 | -15,369 |
| TOTAL | $2,489,063 | $2,382,679 | $1,815,718 | $3,298,830 | $3,197,914 |
| Total Liabilities And Equity | $4,825,780 | $4,615,379 | $4,085,981 | $5,299,132 | $5,179,648 |